NCT01045967View on ClinicalTrials.gov

Lansoprazole 30 mg DR Capsule Fasting Study

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

July 31, 2004

Conditions
Healthy
Interventions
DRUG

Lansoprazole

30 mg delayed-release Capsule

DRUG

Prevacid®

30 mg delayed-release Capsule

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01045967 - Lansoprazole 30 mg DR Capsule Fasting Study | Biotech Hunter | Biotech Hunter